Small molecule antagonists of proteins.

Area of Science:

• Drug Discovery and Development
• Medicinal Chemistry
• Structural Biology

Background:

• Small molecule antagonists targeting protein function are crucial in the pharmaceutical industry.
• Established methods like screening and rational design are used for enzyme and receptor antagonists.
• These techniques are now applied to identify inhibitors of protein-protein interactions (PPIs).

Purpose of the Study:

• To review progress in identifying and designing small molecule inhibitors.
• To specifically focus on inhibitors targeting protein-protein interactions.
• To discuss the physical characteristics of protein-protein interfaces and their impact on drug design.

Main Methods:

• Review of existing literature on small molecule inhibitor discovery.
• Analysis of screening and rational design approaches.
• Examination of protein-protein interface properties.

Main Results:

• Significant advancements have been made in developing small molecule inhibitors for protein-protein interactions.
• Marketed drugs and numerous compounds in development demonstrate the success of these approaches.
• Understanding protein interface biophysics is key for effective lead discovery.

Conclusions:

• The design of small molecule inhibitors for protein-protein interactions is a viable and advancing field.
• Continued research into protein interface characteristics will drive future drug discovery efforts.
• Small molecule inhibitors targeting PPIs represent a growing area of pharmaceutical research and development.